FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3028799211> ?p ?o ?g. }

• W3028799211 endingPage "12" @default.
• W3028799211 startingPage "8" @default.
• W3028799211 abstract "Background Choroidal melanoma(CM)is a common form of primary ocular cancer in adults.It is reported that indomethacin has inhibitory effect on many tumor in vitro and in vivo,but whether it can inhibit the growth of CM has not been published. Objective This study was to investigate the anti-tumor activity of indomethacin on the growth of human CM OCM-1 cell xenografts in nude mice. Methods OCM-1 cells were subcutaneously implanted on 24 SPF female BALB/C.nu/nu nude mice to establish ectopic models of human CM.The nude mice with the tumor 5 mm were randomly divided into 4 groups:untreated group,normal saline solution(NS) group,indomethacin 1 ms/kg group,indomethacin 2 ms/kg group.The 1 mS/kg or 2 ms/kg indomethacin was intraperitoneally injected for 14 consecutive days in indomethacin 1 ms/kg group and indomethacin 2 me/kg group respectively.and 0.2 ml of 2%NS-DMSO was used at a same way in the NS group.No any agent was used as the untreated group.The volume and weight of implanted tumor as well as inhibitory rates of indomethaein on tumor were calculated.The expression of ki67 and survivin proteins were measured with immunohistochemistry,and the expression of survivin mRNA in CM was assessed by RT-PCR. ResuIts The tumor of indomethacin treatment group was reduced in volume and weight with a significant difference between treatment group and control group as well as indomethacin 1 ms/ks group and indomethacin 2 ms/kg group(P＜0.05).The inhibitory rate of indomethacin 1 ms/kg and 2 ms/kg for tumor was 22.86%,48.00%respectively.The prolifiration index (PI)of ki67 in these 4 groups were (76.73±3.34)%,(73.30±2.95)%,(55.97±2.24)%,(32.87±2.91)%respectively,and significant difference was found in PI between indomethacin 2 mg/kg group and untreated group or NS group(P＜0.05),but there was not significant difference between indomethacin 1 mg/kg and 2 ms/kg group(P＞0.05).Compared with the control group,the indomethacin treatment groups showed the decreased expression of survivin protein and mRNA,and significant difference was found between indomethaein 2 ms/kg group and untreated group or NS group(P＜0.05),however,no significant difference was found between indomethacin 1 mg/kg and 2 mg/kg group(P＞0.05). Conclusion Indomethacin inhibits the growth of CM in nude mice through inhibiting the expression of survivin in the tumor and accelerating cell apoptosis and inhibiting tumor cell proliferation.Key words: lndomethacin;  Choroidal melanoma;  Ki67;  Survivin;  Apoptosis" @default.
• W3028799211 created "2020-06-05" @default.
• W3028799211 creator A5022499603 @default.
• W3028799211 creator A5024667774 @default.
• W3028799211 creator A5026664731 @default.
• W3028799211 creator A5052024256 @default.
• W3028799211 creator A5071922281 @default.
• W3028799211 creator A5081069826 @default.
• W3028799211 date "2011-01-10" @default.
• W3028799211 modified "2023-09-26" @default.
• W3028799211 title "Effects of indomethacin on human choroidal melanoma OCM-1 xenografts in nude mouse" @default.
• W3028799211 doi "https://doi.org/10.3760/cma.j.issn.2095-0160.2011.01.003" @default.
• W3028799211 hasPublicationYear "2011" @default.
• W3028799211 type Work @default.
• W3028799211 sameAs 3028799211 @default.
• W3028799211 citedByCount "0" @default.
• W3028799211 crossrefType "journal-article" @default.
• W3028799211 hasAuthorship W3028799211A5022499603 @default.
• W3028799211 hasAuthorship W3028799211A5024667774 @default.
• W3028799211 hasAuthorship W3028799211A5026664731 @default.
• W3028799211 hasAuthorship W3028799211A5052024256 @default.
• W3028799211 hasAuthorship W3028799211A5071922281 @default.
• W3028799211 hasAuthorship W3028799211A5081069826 @default.
• W3028799211 hasConcept C121608353 @default.
• W3028799211 hasConcept C126322002 @default.
• W3028799211 hasConcept C142724271 @default.
• W3028799211 hasConcept C150903083 @default.
• W3028799211 hasConcept C185592680 @default.
• W3028799211 hasConcept C190283241 @default.
• W3028799211 hasConcept C202751555 @default.
• W3028799211 hasConcept C204232928 @default.
• W3028799211 hasConcept C207001950 @default.
• W3028799211 hasConcept C2775975398 @default.
• W3028799211 hasConcept C2776467144 @default.
• W3028799211 hasConcept C2777397205 @default.
• W3028799211 hasConcept C2777658100 @default.
• W3028799211 hasConcept C2780278673 @default.
• W3028799211 hasConcept C2780678043 @default.
• W3028799211 hasConcept C502942594 @default.
• W3028799211 hasConcept C55493867 @default.
• W3028799211 hasConcept C71924100 @default.
• W3028799211 hasConcept C86803240 @default.
• W3028799211 hasConcept C98274493 @default.
• W3028799211 hasConceptScore W3028799211C121608353 @default.
• W3028799211 hasConceptScore W3028799211C126322002 @default.
• W3028799211 hasConceptScore W3028799211C142724271 @default.
• W3028799211 hasConceptScore W3028799211C150903083 @default.
• W3028799211 hasConceptScore W3028799211C185592680 @default.
• W3028799211 hasConceptScore W3028799211C190283241 @default.
• W3028799211 hasConceptScore W3028799211C202751555 @default.
• W3028799211 hasConceptScore W3028799211C204232928 @default.
• W3028799211 hasConceptScore W3028799211C207001950 @default.
• W3028799211 hasConceptScore W3028799211C2775975398 @default.
• W3028799211 hasConceptScore W3028799211C2776467144 @default.
• W3028799211 hasConceptScore W3028799211C2777397205 @default.
• W3028799211 hasConceptScore W3028799211C2777658100 @default.
• W3028799211 hasConceptScore W3028799211C2780278673 @default.
• W3028799211 hasConceptScore W3028799211C2780678043 @default.
• W3028799211 hasConceptScore W3028799211C502942594 @default.
• W3028799211 hasConceptScore W3028799211C55493867 @default.
• W3028799211 hasConceptScore W3028799211C71924100 @default.
• W3028799211 hasConceptScore W3028799211C86803240 @default.
• W3028799211 hasConceptScore W3028799211C98274493 @default.
• W3028799211 hasIssue "01" @default.
• W3028799211 hasLocation W30287992111 @default.
• W3028799211 hasOpenAccess W3028799211 @default.
• W3028799211 hasPrimaryLocation W30287992111 @default.
• W3028799211 hasRelatedWork W2350420545 @default.
• W3028799211 hasRelatedWork W2350656554 @default.
• W3028799211 hasRelatedWork W2357355043 @default.
• W3028799211 hasRelatedWork W2361496678 @default.
• W3028799211 hasRelatedWork W2362923964 @default.
• W3028799211 hasRelatedWork W2366271449 @default.
• W3028799211 hasRelatedWork W2369071974 @default.
• W3028799211 hasRelatedWork W2372595520 @default.
• W3028799211 hasRelatedWork W2373046511 @default.
• W3028799211 hasRelatedWork W2373660558 @default.
• W3028799211 hasRelatedWork W2376976586 @default.
• W3028799211 hasRelatedWork W2380807696 @default.
• W3028799211 hasRelatedWork W2385410762 @default.
• W3028799211 hasRelatedWork W2387524445 @default.
• W3028799211 hasRelatedWork W2389789178 @default.
• W3028799211 hasRelatedWork W2391104601 @default.
• W3028799211 hasRelatedWork W2392475984 @default.
• W3028799211 hasRelatedWork W3028807018 @default.
• W3028799211 hasRelatedWork W3030508989 @default.
• W3028799211 hasRelatedWork W3032413159 @default.
• W3028799211 hasVolume "29" @default.
• W3028799211 isParatext "false" @default.
• W3028799211 isRetracted "false" @default.
• W3028799211 magId "3028799211" @default.
• W3028799211 workType "article" @default.